Syng Pharmaceuticals Inc.

	Address	933 Jasper Crt Kingston, K7P 2A4 Canada
	Address type	Registered Office Address
	Address province	Ontario

	Corporation ID	8322724
	Business number	842703845
	Status	Active
	ACT	Canada Business Corporations Act
	Anniversary date	10/11/2012
	Last annual filing	2025
	Data verified	10/31/2026

Description

Syng Pharmaceuticals Inc. is an active business registered under Canada Business Corporations Act with a corporation no 8322724 (business number 842703845). The incorporation was done on 2012-10-11. The company is based in Kingston at 933 Jasper Crt, K7P 2A4 in Ontario administrative division. As far as we determined, the most recent yearly meeting was held on 2016-11-29.
Additional businesses in the proximity are: National Gaucher Foundation Of Canada, 7224362 Canada Inc., 7151071 Canada Inc., 10293806 Canada Limited, Mapromar Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name	Effective date	Type	Current
SYNG Pharmaceuticals Inc.	10/11/2012	Corporate Name	true

Directors

Vinay Singh
,

last updated: 2026-11-04

Individuals with Significant Control

Individuals who own, control or direct 25% or more of the shares, or have control in fact over the corporation, as reported to Corporations Canada.

VINAY SINGH
Kingston ON
More than 75% of the shares
Owns, controls or directs 25% or more of shares
Holds shares: directly · Control: individually
Since: 10/22/2012

reported to the registry: 12/15/2025 · last checked: 11/04/2026

Annual Filings

Type of corporation	Non-distributing corporation with 50 or fewer shareholders
Annual filing period (MM-DD)	10-11 to 12-10
Last annual meeting	11/28/2025

Year	Annual return
2026	Due to be filed
2025	Filed
2024	Filed

last checked: 11/04/2026

Government Grants and Contributions

2 federal grants and contributions between 2017 and 2025 with a total value of $4,575.

Start date	Department and program	Value
09/07/2025	National Research Council Canada CanExport Innovation (grant) Syng Pharmaceuticals Inc.-2025-2026-1036923 The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to...	$4,575
10/02/2017	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Development of first in vitro diagnostic kit for Endometriosis SYNG Pharma is developing first, in vitro test for endometriosis. This project will validate analytical methods for antigen antibody detection using different matrices, development of lateral flow device and generate new IP for detection of a new biomarker for endometriosis.	$0

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
10/11/2012	Incorporation

Company annual return

Meeting date	Type of corporation	Year of filing
11/29/2016	Non-distributing corporation with 50 or fewer shareholders	2016
10/22/2015	Non-distributing corporation with 50 or fewer shareholders	2015
10/31/2014	Non-distributing corporation with 50 or fewer shareholders	2014